Angle-adjustable PCOS endocrine regulation glasses and method based on AI algorithm

Abstract

The invention belongs to the technical field of PCOS infertility intervention, and particularly discloses angle-adjustable PCOS endocrine regulation glasses and method based on an AI algorithm, the glasses comprise a glasses frame and a glasses bracket, an adjustable light plate is hinged to the glasses frame, an intervention light source is integrated on the inner side of the adjustable light plate, and the irradiation angle of the light source is adjusted through rotation of the adjustable light plate; a pupil distance sensor is arranged on the inner side of the adjustable light plate, a control module is arranged in the lens frame, an AI algorithm is arranged in the control module, target light intensity parameters are calculated through a preset mathematical model, a light source is finely adjusted, and therefore it is ensured that the light intensity accurately acts on a retina target area, and hypothalamic repair hormone secretion is induced. The AI algorithm is linked with the angle of the adjustable light plate and the pupil distance to correct the light intensity in real time, it is ensured that the retina is accurately illuminated, and hypothalamus is effectively induced to repair hormone secretion so as to intervene in PCOS infertility.

Description

Technical Field

[0001] This invention relates to the field of PCOS infertility intervention technology, and in particular to an AI-based angle-adjustable PCOS endocrine regulation glasses and method. Background Technology

[0002] Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by an imbalance in sex hormone secretion (such as high androgen levels and an abnormal LH / FSH ratio). This hormonal imbalance can lead to ovulation dysfunction, becoming one of the main causes of female infertility.

[0003] Current clinical interventions for PCOS-related infertility have many limitations. For example, drug intervention may cause side effects such as ovarian hyperstimulation syndrome and gastrointestinal reactions; surgical intervention is invasive and carries the risk of surgical complications and ovarian function damage.

[0004] In recent years, non-invasive light intervention technology has provided a new approach for PCOS intervention by stimulating the retina-hypothalamic pathway with specific wavelengths of light to regulate hormone secretion. However, existing light intervention devices still have technical shortcomings such as insufficient wearing comfort, low precision in light intensity control, and poor individual adaptability. Traditional devices often cannot adjust the angle and intensity of light application according to individual differences and comfort needs of users, resulting in unstable intervention effects and poor user experience, which affects intervention compliance. Summary of the Invention

[0005] The purpose of this invention is to provide an AI-based angle-adjustable PCOS endocrine regulation glasses to solve the problem that existing technologies cannot achieve precise closed-loop control of light intensity parameters while ensuring wearing comfort.

[0006] To achieve the above objectives, in one aspect, the present invention provides an angle-adjustable PCOS endocrine regulation glasses based on an AI algorithm, comprising a frame and a lens, and further comprising: a dimmable plate hinged to the frame, wherein an intervention light source is integrated on the inner side of the dimmable plate, the intervention light source comprising multiple independent LEDs, the dimmable plate rotating along the hinge axis to adjust the illumination angle of the light source; a pupillary distance sensor disposed on the inner side of the dimmable plate for real-time monitoring of the distance between the light source and the fundus to generate wearing position information; and a control module with a built-in AI algorithm, wherein the AI ​​algorithm calculates the target light intensity parameters based on the light source angle adjusted by the user and the wearing position information detected by the pupillary distance sensor through a preset mathematical model, and fine-tunes the light source to ensure that the light intensity accurately acts on the target area of ​​the retina to induce the secretion of hypothalamic repair hormones.

[0007] Furthermore, the intervention light source includes at least one green LED, at least one red LED, and at least one white LED; the green LED has a wavelength range of 495~570nm and an illuminance of 10Lux~20Lux; the red LED has a wavelength range of 620~700nm and an illuminance of 2Lux~5Lux; and the white LED has an illuminance of 2Lux~5Lux.

[0008] Furthermore, the intervention light source includes a first red LED, a first green LED, a second green LED, a third green LED, a fourth green LED, a second red LED, and a first white LED arranged in sequence.

[0009] Furthermore, the AI-based angle-adjustable PCOS endocrine regulation glasses also include at least one ambient light intensity sensor, which is located at the corner of the frame and collects ambient light intensity at a frequency of 100Hz. When the ambient light intensity fluctuation exceeds ±10%, the AI ​​algorithm compensates and intervenes in the output intensity of the light source in real time. When the ambient light intensity is below 5 Lux or above 1000 Lux, the treatment is automatically paused and a safety warning is triggered.

[0010] Furthermore, a nose pad is connected to the center of the bottom of the frame, and the nose pad includes a bridge support and an adjustable support rod.

[0011] Furthermore, the frame is provided with myopia glasses slots at the hinge points on both sides, the inner wall of the myopia glasses slots is covered with a silicone anti-slip layer, and the opening end is provided with a limiting protrusion to prevent the temple from slipping off.

[0012] Furthermore, the control module also includes a mode button and a mode indicator light, which are located on one side of the frame. When the user triggers a specific mode button, the control module controls the corresponding LED combination to output a preset light intensity and illuminates the corresponding mode indicator light.

[0013] Furthermore, the frame is also equipped with a power switch and a switch indicator light. The switch indicator light is linked to the power switch, and the switch indicator light is lit when the power switch is turned on.

[0014] Furthermore, each of the aforementioned frames is provided with a USB interface at its end, and the USB interface is connected to the control module and the internal power supply through internal circuitry.

[0015] In another aspect, the present invention also provides an angle-adjustable PCOS endocrine regulation method based on an AI algorithm, and based on the AI ​​algorithm-adjustable PCOS endocrine regulation glasses described in any of the above claims, this aspect includes the following steps:

[0016] Step S1: The user manually adjusts the angle of the dimmable plate within the range of 0° to 50° to select a comfortable position and select the preset treatment mode;

[0017] Step S2: The pupil distance sensor collects the distance information between the light source and the pupil in real time;

[0018] Step S3: The AI ​​algorithm in the control module calculates the target light intensity parameters based on the angle adjusted by the user and the collected distance information through a preset mathematical model;

[0019] Step S4: The control module fine-tunes the light source to ensure that the light intensity acts stably on the retina and induces the secretion of repair hormones in the hypothalamus.

[0020] As can be seen from the above structure and method, the present invention uses AI algorithm to link the angle of the adjustable light plate with the pupil distance to correct the light intensity in real time, ensuring that the retina receives light accurately and effectively inducing the secretion of hypothalamic repair hormones to intervene in PCOS infertility. Attached Figure Description

[0021] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0022] Figure 1 This is a schematic diagram of the structure of the angle-adjustable PCOS endocrine regulation glasses according to an embodiment of the present invention. Figure 1 ;

[0023] Figure 2 for Figure 1 A magnified view of a section at point A in the middle;

[0024] Figure 3 This is a schematic diagram of the structure of the angle-adjustable PCOS endocrine regulation glasses according to an embodiment of the present invention. Figure 2 ;

[0025] Figure 4 for Figure 3 A magnified view of a section at point B in the middle;

[0026] Figure 5 This is a schematic diagram of the structure of the angle-adjustable PCOS endocrine regulation glasses according to an embodiment of the present invention. Figure 3 ;

[0027] Figure 6 for Figure 5 A magnified view of a section at point C;

[0028] Figure 7 This is a schematic diagram of the nose pad structure in the glasses according to an embodiment of the present invention.

[0029] In the diagram: 1. Dimmable panel; 2. Ambient light sensor; 3. Frame pattern; 4. Mode button; 41. First button; 42. Second button; 43. Third button; 44. Fourth button; 5. Mode indicator light; 51. First indicator light; 52. Second indicator light; 53. Third indicator light; 54. Fourth indicator light; 6. Switch indicator light; 7. USB interface; 8. Power switch; 9. Intervention light source; 91. First red LED; 92. First green LED; 93. Second green LED; 94. Third green LED; 95. Fourth green LED; 96. Second red LED; 97. First white LED; 10. Pupil distance sensor; 11. Nose pad; 111. Nose bridge support; 112. Adjustable support rod; 12. Prescription glasses slot. Detailed Implementation

[0030] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0031] This invention aims to provide an AI-based angle-adjustable PCOS endocrine regulation glasses and method, solving the problems of uncomfortable wearing and inaccurate light intensity control in existing technologies. By allowing users to adjust the light source angle and combining it with AI algorithm calculations, it achieves precise control of light intensity based on personalized comfort while activating retinal cells to induce the secretion of hypothalamic repair hormones, thereby improving the intervention effect of PCOS infertility.

[0032] To make the above-mentioned objects, features and advantages of the present invention more apparent and understandable, the present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.

[0033] Example 1:

[0034] Reference Figures 1 to 7As shown, this embodiment provides an AI-based angle-adjustable PCOS endocrine regulation glasses for the treatment or prevention of polycystic ovary syndrome and ovarian fibrosis. The glasses include a frame and side frames located on both sides of the frame. A dimmable plate 1 is hinged to the frame, and this dimmable plate 1 can rotate and adjust within a range of 0° to 50° along a horizontal axis. Users can manually adjust the tilt angle of the dimmable plate 1 to select a comfortable wearing position. Multiple intervention light sources 9 for optical intervention are arranged on the inner side of the dimmable plate 1. By adjusting the tilt angle of the dimmable plate 1, the illumination angle of the intervention light sources 9 is changed. Different tilt angles produce different light intensities to meet the needs of different users. Two pupil distance sensors 10 are symmetrically connected to the inner side of the dimmable plate 1 along its center position. These sensors monitor the distance between the light source and the fundus in real time, generating wearing position information. This wearing position information reflects the specific wearing position of the glasses on the user's face and, together with the light source angle, affects the effect of light intensity on retinal cells. The frame houses a control module with a built-in AI algorithm. This algorithm calculates based on the user-adjusted light intensity activation angle and the current position of the nose pad 11. The AI ​​algorithm is pre-trained with extensive clinical and experimental data to establish a mathematical model relating the adjustable light plate angle, the nose pad 11 position, and the light intensity effect. Once the user's adjusted angle and nose pad 11 position are obtained, the AI ​​algorithm uses this mathematical model to calculate the optimal position for maintaining a specific light intensity to activate retinal cells and induce the secretion of hypothalamic repair hormones. It then fine-tunes the angle or intensity of the light-emitting device (if necessary) to ensure the light intensity is accurately applied to the target area.

[0035] In the above embodiments, such as Figure 3 and Figure 7 As shown, a nose pad 11 is connected to the center of the bottom of the frame. The nose pad 11 is rigidly connected to the frame body. Its structure includes a nose bridge support 111 and an adjustable support rod 112. The adjustable support rod 112 adopts a telescopic rod structure and its length can be adjusted. The nose bridge support 111 is made of medical silicone material, which directly fits the user's nose bridge to reduce pressure.

[0036] In one optional embodiment, the nose pad adopts a snap-on design, and the adjustable support rod 112 and the nose bridge support part 111 are snapped together by multiple snaps. By adjusting the snap-on position of the adjustable support rod 112 and the nose bridge support part 111, the height of the nose pad 11 can be adjusted in the vertical direction within a range of 0~1cm, which can adapt to different nose bridge heights and the needs of wearing myopia glasses.

[0037] In the above embodiments, such as Figure 1 and Figure 3As shown, myopia glasses slots 12 are provided on both sides of the frame at the hinge points, allowing myopic users to insert their own myopia glasses temples, thus reusing the space for both treatment glasses and myopia glasses, and achieving a stable wearing of both glasses within a limited space. The myopia glasses slots 12 adopt an inverted U-shaped elastic slot structure, with the depth and width of the slot adapted to the size of mainstream myopia glasses temples, and the inner wall of the slot is covered with a silicone anti-slip layer. Furthermore, a limiting protrusion is provided at the opening end of the myopia glasses slots 12 to prevent the myopia glasses from slipping out.

[0038] When patients need to wear corrective glasses, such as myopia glasses, to ensure clear vision during treatment without affecting their normal activities (such as walking, using the toilet, and drinking), the patient can adjust the nose pads 11 appropriately and insert the myopia glasses into the myopia glasses slots 12 of the treatment glasses before wearing the glasses and undergoing treatment.

[0039] In one specific embodiment, the overall outer shell of the glasses and the dimmable plate 1 are both made of lightweight aluminum alloy, and the surface is CNC machined and UV matte coated.

[0040] In one specific embodiment, the intervention light source 9 is integrated inside the dimmable plate 1. Its light source LEDs can be divided into three colors: green, red, and white. The green light wavelength is between 495 and 570 nm, with a light intensity of 10 to 20 Lux; the red light wavelength is between 620 and 700 nm, with a light intensity of 2 to 5 Lux; and the white light wavelength is between 400 and 700 nm (covering the entire visible spectrum), with a light intensity of 2 to 5 Lux. Specifically, as... Figure 4 As shown, this embodiment includes 7 independent LED beads, arranged in sequence as the first red LED bead 91, the first green LED bead 92, the second green LED bead 93, the third green LED bead 94, the fourth green LED bead 95, the second red LED bead 96, and the first white LED bead 97.

[0041] In one specific embodiment, an ambient light intensity sensor 2 is installed at at least one corner of the mirror frame. Its optical window is flush with the outer surface of the mirror frame, and it houses a broadband photodiode and a visible light filter. It is directly connected to the ADC sampling port of the control module via a flexible circuit. The ambient light intensity sensor 2 collects ambient light intensity at a frequency of 100Hz (accuracy 0.1Lux). When an ambient light intensity fluctuation is detected to be greater than ±10%, an AI algorithm compensates for the output intensity of the intervention light source 9 in real time, ensuring that the treatment light intensity is not affected by environmental interference. If the ambient light intensity is lower than 5Lux or higher than 1000Lux, the treatment is automatically paused and a safety warning is triggered.

[0042] In one specific embodiment, the glasses have a built-in intelligent control system, including a control module located in one side of the frame, a mode button 4, a power switch 8, and a corresponding mode indicator light 5 located on that side of the frame. Specifically, as follows... Figure 6 As shown, the mode button 4 includes a first button 41, a second button 42, a third button 43, and a fourth button 44, which correspond to the four treatment modes of the glasses in this embodiment. The control module can receive light source distance information during the adjustment process, store the data, and output appropriate light intensity parameters based on the received parameter information, thereby controlling the light source intensity to be adjusted to a suitable level.

[0043] Correspondingly, on the side of the frame where the mode button 4 is located, there are four mode indicator lights 5 and one switch indicator light 6, such as... Figure 2 As shown, it specifically includes a first indicator light 51, a second indicator light 52, a third indicator light 53, and a fourth indicator light 54.

[0044] In this embodiment, the intelligent control system is located on the right side of the frame, and correspondingly, the power switch 8 is located on the ventral side of the right side of the frame. Figure 3 As shown, the power switch 8 is linked to the indicator light 6 to indicate the power status.

[0045] The glasses described above include four treatment modes, each composed of different colored LEDs and varying light intensities. Patients can adjust the mode using mode button 4. Button 41 adjusts to Mode 1: 15 Lux green LED, 3 Lux white LED; button 42 adjusts to Mode 2: 15 Lux green LED, 3 Lux red LED; button 43 adjusts to Mode 3: 20 Lux green LED, 5 Lux white LED; and button 44 adjusts to Mode 4: 15 Lux green LED, 5 Lux red LED. The corresponding mode indicator light 5 illuminates when the mode is selected.

[0046] Different treatment modes of the glasses stimulate the retina and act on the central nervous system, relieving chronic inflammation and sympathetic nerve tension in individuals with polycystic ovary syndrome (PCOS). This can effectively improve ovarian fibrosis caused by PCOS and restore a certain degree of reproductive capacity in affected individuals. It does not require surgical or hormone treatment, has almost no damage or long-term effects on the patient's body, and can reduce the patient's medical expenses to some extent.

[0047] When wearing the device, individual differences (including whether the user wears glasses, face size, etc.) and the angle of the dimmable plate 1 can cause variations in the distance between the intervention light source 9 and the patient's pupil, resulting in different light intensity stimuli received by the retina. At this time, the distance sensor in the pupil distance sensor 10 can detect distance changes as small as 0.01 cm. Once the device detects that the user has stably worn the device (after adjusting the position of the dimmable plate 1 and nose pad 11), it can measure the distance between the light source and the retinal cells of the pupil in the current posture. This data is then collected by the chip in the control sensor module, and the AI ​​algorithm is executed to adjust the light intensity, ensuring that the retina receives the appropriate light intensity stimulus. If the angle deviation exceeds ±1% to 5% during use, the distance sensor will be activated to remeasure the distance and adjust the light intensity to ensure that the light intensity always accurately targets the target area and is not attenuated by distance adjustments.

[0048] Each treatment mode lasts for 30 minutes. After the treatment is completed, the intervention light source 9 for the corresponding mode will be turned off.

[0049] In one specific embodiment, the control module uses a low-power W517 chip as the core processor, with built-in computing resources and storage space required for running AI algorithms.

[0050] In some alternative implementations, such as Figure 3 As shown, a USB port 7 is located at the end of the right frame for charging and data communication.

[0051] In some alternative implementations, such as Figure 1 and Figure 2 As shown, a frame pattern 3 is set on the outer surface of the right frame. Specifically, the frame pattern 3 is formed by relief carving, with a pattern depth of 0.2~0.5mm and a matte UV protective layer on the surface to improve wear resistance. The pattern content is the traditional folk culture theme "Qilin Sending a Child", with a line width accuracy of ±0.05mm and an overall size of 15%~20% of the outer surface area of ​​the right frame.

[0052] In one specific embodiment, the pupil distance sensor 10 employs a low-power, short-range, high-precision distance sensor capable of sensing distance changes as small as 0.01 cm. Once the user has stabilized the device (after adjusting the positions of the dimmable plate 1 and nose pad 11), the distance between the light source and the pupil's retinal cells in the current posture can be measured. A corresponding angle sensor is located in the horizontal adjustment axis area; if the angle shifts by more than ±1% to 5% during use, the distance sensor will be activated to re-measure the distance.

[0053] It should be understood that, in practical applications, other frame patterns can be set on the outer surface of the frame on any one or both sides according to the user's actual needs.

[0054] Example 2:

[0055] This invention also provides an AI-based angle-adjustable PCOS endocrine regulation method, using the AI-based angle-adjustable PCOS endocrine regulation glasses described in Embodiment 1 above. The method includes the following steps:

[0056] Step S1: The user manually adjusts the angle of the dimmable plate 1 within the range of 0° to 50° to select a comfortable position and select the preset treatment mode;

[0057] Step S2: The pupil distance sensor 10 collects the distance information between the light source and the pupil in real time;

[0058] Step S3: The AI ​​algorithm in the control module calculates the target light intensity parameters based on the angle adjusted by the user and the collected distance information through a preset mathematical model;

[0059] Step S4: The control module fine-tunes the light source to ensure that the light intensity acts stably on the retina and induces the secretion of repair hormones in the hypothalamus.

[0060] In one specific embodiment, in step S1, if the user is wearing the device for the first time, an initial wearing registration is required. The user registers personal information through the device's accompanying application, including: age, gender, severity of PCOS, basic vision status, etc.

[0061] In step S1, the bottom of the dimmable plate 1 can be aligned with the top of the user's eyes by adjusting the height of the nose pad 11; if the user needs to wear other corrective glasses such as myopia glasses at the same time, the temples of the myopia glasses can be inserted into the myopia glasses slot 12.

[0062] Users can manually adjust the angle of the light source of the light-emitting device according to their own comfort. During the adjustment process, the distance sensor of the dimmable plate 1 collects the distance information of the light source and transmits this information along with the angle information to the control module. The control module stores the received data and outputs appropriate light intensity parameters based on the received parameter information, controlling the glasses to change the light source to a suitable intensity.

[0063] After completing the above adjustments, press the power switch 8 to start the device. The switch indicator light 6 will light up, and the ambient light intensity sensor 2 and the pupil distance sensor 10 will be activated simultaneously.

[0064] In step S1, the user selects a preset treatment mode via mode button 4. In this embodiment, the preset treatment modes include the following four:

[0065] Mode 1: Press the first button 41 to activate the green LED and white LED. The green LED outputs a light intensity of 15 Lux, and the white LED outputs a light intensity of 3 Lux. The first indicator light 51 will light up.

[0066] Mode 2: Press the second button 42 to activate the green LED and the red LED. The green LED outputs a light intensity of 15 Lux, and the red LED outputs a light intensity of 3 Lux. The second indicator light 52 will light up.

[0067] Mode 3: Press the third button 43 to activate the green LED and the white LED. The green LED outputs a light intensity of 20 Lux, and the white LED outputs a light intensity of 5 Lux. The third indicator light 53 will light up.

[0068] Mode 4: Press the fourth button 44 to activate the green LED and the red LED. The green LED outputs a light intensity of 15 Lux, and the red LED outputs a light intensity of 5 Lux. The fourth indicator light 54 will light up.

[0069] In one specific embodiment, in step S2, the pupil distance sensor 10 monitors the distance between the intervention light source 9 and the fundus cells in real time with an accuracy of 0.01cm; the ambient light intensity sensor 2 collects the ambient light intensity at a frequency of 100Hz; the built-in angle sensor captures the real-time tilt angle of the dimmable plate 1; the multiple sensors work together to collect data and transmit it to the W517 chip of the control module via the SPI bus.

[0070] In one specific embodiment, in step S3, the AI ​​algorithm in the control module processes and calculates the input light source-fundus distance, ambient light intensity, light source tilt angle, and nose pad 11 position information according to a preset mathematical model, and determines the appropriate position parameters that can activate retinal cells with specific light intensity to induce the secretion of hypothalamic repair hormones.

[0071] In one specific embodiment, if the ambient light intensity fluctuates by more than ±10%, the AI ​​algorithm increases / decreases the light source intensity according to a preset formula.

[0072] In one specific embodiment, the AI ​​algorithm calculation and adjustment includes: after receiving the distance and angle information of the light source, the AI ​​algorithm in the control module immediately performs calculations based on a pre-trained mathematical model to determine the appropriate positional parameters within 100ms that can activate retinal cells with specific light intensity to induce the secretion of hypothalamic repair hormones.

[0073] In one specific embodiment, the intervention process is also monitored and fed back. Specifically, during the intervention, if the light source angle information changes, the sensor corrects the light source angle information. If a significant change in the glasses position is detected, the control module immediately restarts the AI ​​algorithm for calculation and adjusts the light-emitting device accordingly to ensure that the light intensity always accurately acts on the target area, unaffected by attenuation after distance adjustment. This ensures that the user can achieve the same activation stimulation in any natural and comfortable posture. It also ensures that the PCOS light intervention effect is controllable.

[0074] In one specific embodiment, during the intervention process monitoring, the following parameter changes are monitored in real time: tilt offset of the dimmable plate 1 > ±1%; change in the distance between the light source and the fundus > ±1%; ambient light intensity < 5 Lux (dark environment) or > 1000 Lux (strong light environment). When the above parameter changes occur, a dynamic response is initiated. For example, when the angle / distance exceeds the limit, the pupil distance sensor 10 is triggered to remeasure the distance, and the AI ​​algorithm recalibrates the light intensity within 50ms; when the ambient light is abnormal, treatment is immediately paused, and the indicator light 6 flashes red as a warning; when the user's posture changes, after the nose pad 11 is adjusted in height, the AI ​​synchronously optimizes the light source output to compensate for the vertical displacement effect.

[0075] In one specific embodiment, after a preset treatment time (e.g., 30 minutes), the treatment cycle automatically ends, the intervention light source 9 automatically turns off, and the mode indicator light 5 goes out. Simultaneously, the distance, angle, and light intensity parameters during the treatment process are automatically stored in the control module, or uploaded to the cloud platform via USB interface 7 or a wireless transmission channel.

[0076] In one specific embodiment, the data model of the AI ​​algorithm is periodically optimized. For example, when 1,000 new data sets are added, the cloud performs the following: retraining the neural network model (learning rate 0.001, 50 epochs); updating the device's local AI algorithm parameters to adapt to individual physiological changes (such as hormonal secretion cycle fluctuations).

[0077] In one specific embodiment, the training and optimization of the AI ​​algorithm includes the following steps:

[0078] Data Collection: Patients diagnosed with PCOS-related infertility underwent a light intensity intervention experiment while wearing testing glasses under the guidance of professional medical personnel. During the experiment, information on each adjustment of the light source angle and nose pad position was recorded. Simultaneously, physiological indicators such as hormone secretion levels and retinal cell activation were collected in real time under different light intensities using professional medical testing equipment (such as blood hormone analyzers and retinal cell activity analyzers). A total of 10,000 data samples were collected.

[0079] Model Construction and Training: Based on the collected data, a neural network model was constructed using the deep learning framework TensorFlow. The angle of the adjustable light plate 1 and the position of the nose pad 11 were used as input layer parameters, and a specific light intensity parameter that can effectively activate retinal cells and induce the secretion of hypothalamic repair hormones was used as the output layer parameters. The neural network was trained using the stochastic gradient descent algorithm with a learning rate of 0.001 and a training period of 50 epochs. By continuously adjusting the model parameters, the error between the model's predicted light intensity parameters and the actual effective light intensity parameters was minimized, ultimately achieving a prediction accuracy of over 95%.

[0080] Model Optimization and Updates: Establish a cloud-based data management platform to continuously collect user data during actual use and regularly optimize and update the AI ​​algorithm model. When the collected new data reaches a certain scale (e.g., every 1000 new sets of valid data), the model is retrained to adapt to different individual differences and physiological changes during intervention, continuously improving the accuracy and adaptability of the AI ​​algorithm.

[0081] Compared with the prior art, the present invention discloses at least the following beneficial effects:

[0082] This invention uses an adjustable light plate 1 with an adjustable horizontal tilt angle, allowing users to manually adjust the light source illumination angle according to individual comfort. Combined with the height adjustment function of the adjustable nose pad 11, it significantly improves wearing comfort and fit, thereby improving treatment compliance. At the same time, the pupil distance sensor 10 monitors the distance between the light source and the fundus in real time, and works with the ambient light intensity sensor 2 to collect ambient light data, forming a dynamic sensing network.

[0083] The aforementioned structure directly supports the precise control of the AI ​​algorithm: based on the light source distance, nose pad 11 position, and ambient light intensity parameters collected by the sensors, the control module calculates the optimal light intensity output parameters within 100ms using a pre-trained mathematical model, driving the LED combination of the intervention light source 9 to output a specific light intensity according to a preset mode. This closed-loop control mechanism ensures that the light intensity always precisely acts on the target area of ​​the retina, effectively activating the secretion of hypothalamic repair hormones and overcoming the problem of light intensity attenuation caused by wearing displacement or environmental interference.

[0084] Furthermore, the inverted U-shaped elastic structure of the myopia glasses slot 12 is linked with the nose pad 11 height adjustment technology, allowing users to wear corrective glasses on top of each other to ensure normal visual field during treatment; the layout design of the mode button 4 and the mode indicator light 5 provides intuitive operation feedback and ensures reliable switching between the four spectral modes.

[0085] Ultimately, through the synergy of mechanical structure, sensing system, and AI algorithm, this technical solution transforms personalized and comfortable wearing into quantifiable and controllable optical intervention parameters, providing a non-invasive, stable, and user-friendly non-drug intervention method for PCOS infertility, significantly improving ovarian fibrosis and restoring reproductive potential.

[0086] In the description of this invention, it should be understood that the terms "longitudinal", "lateral", "up", "down", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this invention, and are not intended to indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this invention.

[0087] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.

Claims

1. An AI-based angle-adjustable PCOS endocrine regulation glasses, comprising a frame and a lens, characterized in that, Also includes: A dimmable plate (1) is hinged to the frame. An intervention light source (9) is integrated inside the dimmable plate (1). The intervention light source (9) includes multiple independent LEDs. The dimmable plate (1) rotates along the hinge axis to adjust the illumination angle of the light source. A pupil distance sensor (10) is disposed inside the dimmable plate (1) to monitor the distance between the light source and the fundus in real time to generate wearing position information; The control module has a built-in AI algorithm. The AI ​​algorithm calculates the target light intensity parameters based on the light source angle adjusted by the user and the wearing position information detected by the pupil distance sensor (10) through a preset mathematical model, and fine-tunes the light source to ensure that the light intensity accurately acts on the target area of ​​the retina and induces the secretion of hypothalamic repair hormones.

2. The AI-based adjustable PCOS endocrine regulation glasses according to claim 1, characterized in that, The intervention light source (9) includes at least one green LED, at least one red LED, and at least one white LED; the wavelength range of the green LED is 495~570nm, and the illuminance is 10Lux~20Lux; the wavelength range of the red LED is 620~700nm, and the illuminance is 2Lux~5Lux; the illuminance of the white LED is 2Lux~5Lux.

3. The angle-adjustable PCOS endocrine regulation glasses based on AI algorithm according to claim 2, characterized in that, The intervention light source (9) includes a first red LED (91), a first green LED (92), a second green LED (93), a third green LED (94), a fourth green LED (95), a second red LED (96), and a first white LED (97) arranged in sequence.

4. The angle-adjustable PCOS endocrine regulation glasses based on AI algorithm according to claim 1, characterized in that, It also includes at least one ambient light intensity sensor (2), which is located at the corner of the frame and collects ambient light intensity at a frequency of 100Hz. When the ambient light intensity fluctuation exceeds ±10%, the AI ​​algorithm compensates for the output intensity of the intervention light source (9) in real time. When the ambient light intensity is lower than 5Lux or higher than 1000Lux, the treatment is automatically suspended and a safety warning is triggered.

5. The angle-adjustable PCOS endocrine regulation glasses based on AI algorithm according to claim 1, characterized in that, The nose pad (11) is connected to the center of the bottom of the frame. The nose pad (11) includes a nose bridge support (111) and an adjustable support rod (112).

6. The AI-based adjustable PCOS endocrine regulation glasses according to claim 5, characterized in that, The frame is provided with myopia glasses slots (12) at the hinges between the frame and the frame. The inner wall of the myopia glasses slots (12) is covered with a silicone anti-slip layer, and the opening end is provided with a limiting protrusion to prevent the temple from slipping off.

7. The angle-adjustable PCOS endocrine regulation glasses based on AI algorithm according to claim 1, characterized in that, The control module also includes a mode button (4) and a mode indicator light (5). The mode button (4) and the mode indicator light (5) are located on one side of the frame. When the user triggers a specific mode button (4), the control module controls the corresponding LED combination to output a preset light intensity and lights up the corresponding mode indicator light (5).

8. The AI-based adjustable PCOS endocrine regulation glasses according to claim 7, characterized in that, The frame is also equipped with a power switch (8) and a switch indicator light (6). The switch indicator light (6) is linked with the power switch (8). When the power switch (8) is turned on, the switch indicator light (6) is lit.

9. The AI-based adjustable PCOS endocrine regulation glasses according to claim 1 or 7, characterized in that, Each of the eyeglass frames is provided with a USB interface (7) at its end, and the USB interface (7) is connected to the control module and the internal power supply through an internal circuit.

10. A method for angle-adjustable PCOS endocrine regulation based on AI algorithms, using the angle-adjustable PCOS endocrine regulation glasses based on AI algorithms as described in any one of claims 1 to 8, characterized in that... Includes the following steps: Step S1: The user manually adjusts the angle of the dimmable plate (1) to select a comfortable position within the range of 0°~50°, and selects the preset treatment mode; Step S2: The pupil distance sensor (10) collects the distance information between the light source and the pupil in real time; Step S3: The AI ​​algorithm in the control module calculates the target light intensity parameters based on the angle adjusted by the user and the collected distance information through a preset mathematical model; Step S4: The control module fine-tunes the light source to ensure that the light intensity acts stably on the retina and induces the secretion of repair hormones in the hypothalamus.

Images